C
Christopher J. Harrison
Researcher at Children's Mercy Hospital
Publications - 125
Citations - 5126
Christopher J. Harrison is an academic researcher from Children's Mercy Hospital. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 30, co-authored 104 publications receiving 4361 citations. Previous affiliations of Christopher J. Harrison include University of Missouri–Kansas City & University of Pittsburgh.
Papers
More filters
Journal ArticleDOI
The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America
John S. Bradley,Carrie L. Byington,Samir S. Shah,Brian Alverson,Edward R. Carter,Christopher J. Harrison,Sheldon L. Kaplan,Sharon E. Mace,George H. McCracken,Matthew R. Moore,Shawn D. St. Peter,Jana A. Stockwell,Jack Swanson +12 more
TL;DR: Eidenced-based guidelines for management of infants and children with community-acquired pneumonia (CAP) were prepared by an expert panel comprising clinicians and investigators representing community pediatrics, public health, and the pediatric specialties of critical care, emergency medicine, hospital medicine, infectious diseases, pulmonology, and surgery.
Journal ArticleDOI
Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media.
Stan L. Block,James Hedrick,Christopher J. Harrison,Ron Tyler,Alan D. Smith,Rebecca Findlay,Eileen Keegan +6 more
TL;DR: The overall proportion of S. pneumoniae isolates and vaccine serotypes in AOM were significantly reduced by community-wide use of PCV7 vaccine in the practice of this 7-clinician, pediatric practice in rural central Kentucky.
Journal ArticleDOI
Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management.
Stan L. Block,Christopher J. Harrison,James Hedrick,Ronald D. Tyler,Renee Smith,Eileen Keegan,Stephen A. Chartrand +6 more
TL;DR: From 1992 to 1994, penicillin-resistant (minimal inhibition concentration (MIC) > 0.06 μg/ml) Streptococcus pneumoniae (PRSP) isolates accounted for 48 (17%) of 283 isolates from acute otitis media (AOM) or recurrent AOM in 246 ambulatory patients in rural Kentucky as discussed by the authors.
Journal ArticleDOI
Thoracoscopic decortication vs tube thoracostomy with fibrinolysis for empyema in children: a prospective, randomized trial
Shawn D. St. Peter,KuoJen Tsao,Christopher J. Harrison,Mary Ann Jackson,Troy L. Spilde,Scott J. Keckler,Susan W. Sharp,Walter S. Andrews,George W. Holcomb,Daniel J. Ostlie +9 more
TL;DR: There are no therapeutic or recovery advantages between VATS and fibrinolysis for the treatment of empyema; however, VATS resulted in significantly greater charges and should be the first-line therapy for children withEmpyema.
Journal ArticleDOI
Effectiveness of Pentavalent and Monovalent Rotavirus Vaccines in Concurrent Use Among US Children <5 Years of Age, 2009–2011
Daniel C. Payne,Julie A. Boom,Julie A. Boom,Mary Allen Staat,Kathryn M. Edwards,Peter G. Szilagyi,Eileen J. Klein,Rangaraj Selvarangan,Parvin H. Azimi,Christopher J. Harrison,Mary E. Moffatt,Samantha H. Johnston,Leila C. Sahni,Carol J. Baker,Marcia A. Rench,Stephanie Donauer,Monica M. McNeal,James D. Chappell,Geoffrey A. Weinberg,Azadeh Tasslimi,Jacqueline E. Tate,Mary E. Wikswo,Aaron T. Curns,Iddrisu Sulemana,Slavica Mijatovic-Rustempasic,Mathew D. Esona,Michael D. Bowen,Jon R. Gentsch,Umesh D. Parashar +28 more
TL;DR: Both RV5 and RV1 significantly protected against medically attended rotavirus gastroenteritis in this real-world assessment, with RV5 providing genotype-specific protection against each of the predominant strains, while RV1 VE was statistically significant for the most common genotypes.